FocuSSced on the Target in Systemic Sclerosis-Interstitial Lung Disease Another Arrow in the Quiver?

被引：0
|
作者：
Matson, Scott M. [1 ]
Griffith, Melissa [2 ]
Lee, Joyce S. [2 ]
机构：
[1] Univ Kansas, Dept Med, Sch Med, Kansas City, KS 66160 USA
[2] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷 / 06期
关键词：
DOUBLE-BLIND; CYCLOPHOSPHAMIDE; PLACEBO;
D O I：
10.1164/rccm.202111-2587ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：608 / 610
页数：4
相关论文
共 50 条
  • [41] Pathogenesis of interstitial lung disease in systemic sclerosis
    Goldman, Nina
    Ong, Voon H.
    Denton, Christopher P.
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2024, 5 (03): : 141 - 151
  • [42] Systemic Sclerosis Associated Interstitial Lung Disease
    Steen, Virginia
    Weir, Nargues
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 110 - 118
  • [43] Systemic sclerosis associated interstitial lung disease
    Xanthouli, P.
    Hermann, W.
    Hunzelmann, N.
    Kreuter, M.
    PNEUMOLOGE, 2018, 15 (06): : 383 - 395
  • [44] Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD)
    Al-Adwi, Yehya
    Westra, Johanna
    van Goor, Harry
    van Kempen, Leon C.
    Osman, Mohammed
    Gan, C. Tji
    Timens, Wim
    Mulder, Douwe J.
    JOURNAL OF AUTOIMMUNITY, 2024, 148
  • [45] Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review
    Campochiaro, Corrado
    Lazzaroni, Maria Grazia
    Bruni, Cosimo
    Zanatta, Elisabetta
    De Luca, Giacomo
    Matucci-Cerinic, Marco
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [46] Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
    Sugimoto, Tomohiro
    Yoshida, Yusuke
    Mokuda, Sho
    Hirata, Shintaro
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (01)
  • [47] An innovative technique for lung isolation in pediatric patient: Another arrow in the quiver!
    Patel, Nishant
    Tripta, Kumari
    Choudhary, Nitin
    Jain, Vishesh
    PEDIATRIC ANESTHESIA, 2024, 34 (01) : 94 - 95
  • [48] Transcriptomic Analyses of Lung Tissues Reveals Potential Key Genes Associated with Progression of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD)
    Al-Adwi, Yehya
    Westra, Johanna
    van Goor, Harry
    van Kempen, Leon. C. L. T.
    Timens, Wim
    Gan, C. Tji
    Mulder, Douwe J.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1587 - 1589
  • [49] Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
    Campochiaro, Corrado
    De Luca, Giacomo
    Lazzaroni, Maria-Grazia
    Armentaro, Giuseppe
    Spinella, Amelia
    Vigone, Barbara
    Ruaro, Barbara
    Stanziola, Anna
    Benfaremo, Devis
    De Lorenzis, Enrico
    Moccaldi, Beatrice
    Bosello, Silvia Laura
    Cuomo, Giovanna
    Beretta, Lorenzo
    Zanatta, Elisabetta
    Giuggioli, Dilia
    Del Papa, Nicoletta
    Airo, Paolo
    Confalonieri, Marco
    Moroncini, Gianluca
    Dagna, Lorenzo
    Matucci-Cerinic, Marco
    RMD OPEN, 2023, 9 (01):
  • [50] Changes in Treatment Patterns and Their Influence on the Outcome of Systemic Sclerosis-interstitial Lung Disease (SSc-ILD) Patients: An EUSTAR Analysis
    Campochiaro, Corrado
    Truchetet, Marie-Elise
    Vonk, Madelon
    Cuomo, Giovanna
    Ananieva, Lidia P.
    Hachulla, Eric
    Smith, Vanessa
    Gheorghiu, Ana Maria
    Becvar, Radim
    Hunzelmann, Nicolas
    Furst, Daniel
    Ortiz-Santamaria, Vera
    Carreira, Patricia
    Del Galdo, Francesco
    Cerinic, Marco Matucci
    Hoffmann-Vold, Anna Maria
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1323 - 1325
12345